financetom
Business
financetom
/
Business
/
What's Going On With Synaptogenix (SNPX) Stock?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Synaptogenix (SNPX) Stock?
Apr 4, 2024 9:26 AM

Synaptogenix Inc ( SNPX ) shares are trading slightly higher Thursday morning after the company announced a 1-for-25 reverse stock split.

This move aims to increase the per-share trading price to meet Nasdaq’s minimum bid price requirement. The reverse split will occur on Thursday with trading on a split-adjusted basis starting on Friday.

The reverse split will uniformly affect all shareholders and reduce outstanding shares from 27,133,349 to about 1,085,333, with proportional adjustments made for equity awards, convertible preferred stock, and warrants.

See Also: HubSpot Stock Jumps As Alphabet Considers Acquisition Offer: The Details

How To Buy SNPX Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Synaptogenix’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, SNPX has a 52-week high of $1.88 and a 52-week low of $0.14.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
The Oncology Institute Q4 Loss Widens, Revenue Increases
The Oncology Institute Q4 Loss Widens, Revenue Increases
Mar 27, 2024
04:46 PM EDT, 03/27/2024 (MT Newswires) -- The Oncology Institute ( TOI ) reported a Q4 loss late Wednesday of $0.21 per diluted share, compared with a loss of $0.16 a year earlier. GAAP EPS was not available on Capital IQ for comparison. Operating revenue for the quarter that ended Dec. 31 was $85.8 million, up from $71.4 million a...
Five Star Bancorp Launches Share Offering
Five Star Bancorp Launches Share Offering
Mar 27, 2024
04:49 PM EDT, 03/27/2024 (MT Newswires) -- Five Star Bancorp ( FSBC ) said Wednesday it has initiated an underwritten public offering of its common shares. The company said it plans to grant the underwriters a 30-day option to purchase additional shares. The size and pricing of the offer weren't disclosed. The company said it intends to use the proceeds...
LendingTree Gets $175 Million Loan Facility From Apollo Funds
LendingTree Gets $175 Million Loan Facility From Apollo Funds
Mar 27, 2024
04:59 PM EDT, 03/27/2024 (MT Newswires) -- LendingTree ( TREE ) said late Wednesday that it has obtained a first lien term loan facility of up to $175 million from funds managed by Apollo affiliates. The firm said it plans to draw $125 million of the facility while the remainder will be available during the following 12 months. The funds...
TD Synnex Announces Secondary Public Stock Offering, Share Repurchase
TD Synnex Announces Secondary Public Stock Offering, Share Repurchase
Mar 27, 2024
04:49 PM EDT, 03/27/2024 (MT Newswires) -- TD Synnex ( SNX ) late Wednesday announced a proposed secondary offering of 9 million shares held by entities managed by affiliates of Apollo Global Management ( APO ) . Underwriters will get a 30-day option to buy up to an additional 1.35 million shares from the selling shareholders, TD SYNNEX ( SNX...
Copyright 2023-2026 - www.financetom.com All Rights Reserved